Disease progression in chronic hepatitis C: Modifiable and nonmodifiable factors

被引:163
作者
Missiha, Sharif B. [1 ]
Ostrowski, Mario [1 ]
Heathcote, E. Jenny [1 ]
机构
[1] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
关键词
D O I
10.1053/j.gastro.2008.02.069
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The hepatic complications of chronic hepatitis C (CHC) usually occur only after progression to cirrhosis has taken place. Progression to cirrhosis, however, is extremely variable and depends on a broad set of host and viral factors that modify the rate at which fibrosis develops in a given individual. Despite their inherent limitations, studies of the natural history of CHC have identified several nonmodifiable factors associated with disease progression. These include age at acquisition of infection, sex, and race. More recent reports suggest important roles for host genetic polymorphisms and viral factors. Of greater immediate relevance to patients and their clinicians are the potentially modifiable factors, which include excessive alcohol consumption; smoking (tobacco and marijuana); insulin resistance; and coinfection with hepatitis B virus, human immunodeficiency virus type 1, or schistosomiasis. Unfortunately, to date, there are no reliable predictive models that can accurately estimate the risk of CHC disease progression.
引用
收藏
页码:1699 / 1714
页数:16
相关论文
共 242 条
  • [1] Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: Interaction with IL-10 gene polymorphisms
    Aborsangaya, Koko Bate
    Dembinski, Iga
    Khatkar, Suresh
    Alphonse, Martin Prince
    Nickerson, Peter
    Rempel, Julia D.
    [J]. HEPATOLOGY, 2007, 45 (03) : 623 - 630
  • [2] Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
    Adinolfi, LE
    Gambardella, M
    Andreana, A
    Tripodi, MF
    Utili, R
    Ruggiero, G
    [J]. HEPATOLOGY, 2001, 33 (06) : 1358 - 1364
  • [3] Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C
    Adinolfi, LE
    Ingrosso, D
    Cesaro, G
    Cimmino, A
    D'Antò, M
    Capasso, R
    Zappia, V
    Ruggiero, G
    [J]. HEPATOLOGY, 2005, 41 (05) : 995 - 1003
  • [4] Afdhal N, 2004, HEPATOLOGY, V40, p239A
  • [5] Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor β that can suppress HCV-specific T-cell responses
    Alatrakchi, Nadia
    Graham, Camilla S.
    van der Vliet, Hans J. J.
    Sherman, Kenneth E.
    Exley, Mark A.
    Koziel, Margaret James
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (11) : 5882 - 5892
  • [6] EVIDENCE FOR A LINK BETWEEN HEPATITIS-C VIRUS-INFECTION AND DIABETES-MELLITUS IN A CIRRHOTIC POPULATION
    ALLISON, MED
    WREGHITT, T
    PALMER, CR
    ALEXANDER, GJM
    [J]. JOURNAL OF HEPATOLOGY, 1994, 21 (06) : 1135 - 1139
  • [7] A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C
    Alsatie, Mazen
    Kwo, Paul Y.
    Gingerich, Joel R.
    Qi, Rong
    Eckert, George
    Cummings, Oscar W.
    Imperiale, Thomas F.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (04) : 416 - 421
  • [8] Alcohol use and treatment of hepatitis C virus: Results of a national multicenter study
    Anand, Bhupinder S.
    Currie, Sue
    Dieperink, Eric
    Bin, Edmund J.
    Shen, Hui
    Ho, Samuel B.
    Wright, Teresa
    [J]. GASTROENTEROLOGY, 2006, 130 (06) : 1607 - 1616
  • [9] AN UPDATED CORONARY RISK PROFILE - A STATEMENT FOR HEALTH-PROFESSIONALS
    ANDERSON, KM
    WILSON, PWF
    ODELL, PM
    KANNEL, WB
    [J]. CIRCULATION, 1991, 83 (01) : 356 - 362
  • [10] Chronic liver disease in the Alexandria governorate, Egypt: Contribution of schistosomiasis and hepatitis virus infections
    Angelico, M
    Renganathan, E
    Gandin, C
    Fathy, M
    Profili, MC
    Refai, W
    DeSantis, A
    Nagi, A
    Amin, G
    Capocaccia, L
    Callea, F
    Rapicetta, M
    Badr, G
    Rocchi, G
    [J]. JOURNAL OF HEPATOLOGY, 1997, 26 (02) : 236 - 243